Intellia Therapeutics shares owned by Bayesian Capital Management
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Bayesian Capital Management
from 13F filings
Historical chart of Bayesian Capital Management investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intellia Therapeutics by Bayesian Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $680k | 30k | 22.38 |
2024-03-31 | $303k | 11k | 27.51 |
2023-03-31 | $306k | 8.2k | 37.27 |
2022-03-31 | $301k | 4.1k | 72.60 |
2020-03-31 | $132k | 11k | 12.22 |
More positions owned by Bayesian Capital Management
View all positions for Bayesian Capital Management